JD Vance Predicts: Wall Street vs. Trump & Your Money

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.

Elias A. Zerhouni net worth and biography

Elias Zerhouni Biography and Net Worth

Director of Danaher

Dr. Zerhouni served as President, Global Research & Development, for Sanofi S.A., a global pharmaceutical company, from 2011 to June 2018. From 2008 until 2011, he provided advisory and consulting services to various non-profit and other organizations as Chairman and President of Zerhouni Holdings. From 2002 to 2008, Dr. Zerhouni served as director of the National Institutes of Health, and from 1996 to 2002, he served as Chair of the Russell H. Morgan Department of Radiology and Radiological Sciences, Vice Dean for Research and Executive Vice Dean of the Johns Hopkins School of Medicine.

Dr. Zerhouni, a physician, scientist and world-renowned leader in radiology research, is widely viewed as one of the leading authorities in the United States on emerging trends and issues in medicine and medical care. These insights, as well as his deep, technical knowledge of the research and clinical applications of medical technologies, are of considerable importance given Danaher’s strategic focus in the medical technologies markets. Dr. Zerhouni’s government experience also gives him a strong understanding of how government agencies work, and his experience growing up in North Africa, together with the global nature of the issues he faced at NIH and his role at France-based Sanofi, give him a global perspective that is valuable to Danaher.

What is Elias A. Zerhouni's net worth?: The estimated net worth of Elias A. Zerhouni is at least $4.74 billion as of January 5th, 2024. Dr. Zerhouni owns 20,327,814 shares of Danaher stock worth more than $4,738,413,443 as of November 21st. This net worth estimate does not reflect any other investments that Dr. Zerhouni may own. Learn More about Elias A. Zerhouni's net worth.
How do I contact Elias A. Zerhouni?: The corporate mailing address for Dr. Zerhouni and other Danaher executives is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. Danaher can also be reached via phone at (202) 828-0850 and via email at [email protected]. Learn More on Elias A. Zerhouni's contact information.
Has Elias A. Zerhouni been buying or selling shares of Danaher?: Elias A. Zerhouni has not been actively trading shares of Danaher during the last ninety days. Most recently, Elias A. Zerhouni sold 3,409 shares of the business's stock in a transaction on Monday, November 29th. The shares were sold at an average price of $328.42, for a transaction totalling $1,119,583.78. Learn More on Elias A. Zerhouni's trading history.
Who are Danaher's active insiders?: Danaher's insider roster includes Rainer Blair (President, CEO & Director), Daniel Comas (EVP), Georgeann Couchara (SVP), William Daniel (EVP), Brian Ellis (SVP), Linda Filler (Director), Jose-Carlos Gutierrez-Ramos (SVP), Linda Hefner (Director), Jennifer Honeycutt (EVP), Thomas Joyce, Jr. (CEO), William King (SVP), Angela Lalor (SVP), Angela Lalor (SVP), Teri List (Director), Walter Lohr (Director), Robert Lutz (CAO), Matthew McGrew (CFO), Mitchell Rales (Chairman), Daniel Raskas (SVP), John Schwieters (Director), Alan Spoon (Director), Raymond Stevens (Director), Joakim Weidemanis (EVP), and Elias Zerhouni (Director). Learn More on Danaher's active insiders.
Are insiders buying or selling shares of Danaher?: In the last twelve months, insiders at the conglomerate sold shares 16 times. They sold a total of 221,399 shares worth more than $56,844,951.46. The most recent insider tranaction occured on August, 26th when SVP Georgeann Couchara sold 952 shares worth more than $255,488.24. Insiders at Danaher own 10.9% of the company. Learn More about insider trades at Danaher.
Information on this page was last updated on 8/26/2024.

Elias A. Zerhouni Insider Trading History at Danaher

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/29/2021	Sell	3,409	$328.42	$1,119,583.78

Elias A. Zerhouni Buying and Selling Activity at Danaher

Danaher Company Overview

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Today's Range

Now: $233.10

$228.89

$233.73

50 Day Range

MA: $259.67

$229.50

$278.02

2 Week Range

Now: $233.10

$213.61

$281.70

Volume

2,642,129 shs

Average Volume

3,170,196 shs

Market Capitalization

$168.36 billion

P/E Ratio

44.48

Dividend Yield

0.47%

Beta

0.85